Edition:
India

Shire PLC (SHP.L)

SHP.L on London Stock Exchange

3,821.50GBp
20 Apr 2018
Change (% chg)

-153.50 (-3.86%)
Prev Close
3,975.00
Open
3,800.00
Day's High
3,946.00
Day's Low
3,744.00
Volume
9,676,315
Avg. Vol
3,671,551
52-wk High
5,021.00
52-wk Low
2,940.50

Select another date:

Fri, Apr 20 2018

Photo

Japan's Takeda sweetens $62 billion Shire offer

TOKYO/LONDON Japan's Takeda Pharmaceutical nudged up its offer for Shire to 44.3 billion pounds ($62 billion) on Friday to try to persuade the rare-disease drugs specialist into talks after it rejected three previous proposals. | Video

Japan's Takeda sweetens $62 billion Shire offer

TOKYO/LONDON Japan's Takeda Pharmaceutical nudged up its offer for Shire to 44.3 billion pounds ($62 billion) on Friday to try to persuade the rare-disease drugs specialist into talks after it rejected three previous proposals.

UPDATE 4-Japan's Takeda sweetens $62 billion Shire offer

* Takeda makes fourth cash and shares bid at 47-pounds-a-share

BRIEF-Shire Says Considering Position With Respect To Fourth Proposal From Takeda

* SHIRE PLC - STATEMENT RE PROPOSAL FROM TAKEDA PHARMACEUTICAL COMPANY LIMITED ("TAKEDA")

UPDATE 1-FTSE 100 posts fourth straight week of gains while Reckitt, Shire fall

* Shire falls after Allergan rules out bid (Adds closing prices)

Takeda ups Shire offer to 47 pounds-a-share

LONDON, April 20 Japan's Takeda Pharmaceutical Co Ltd increased its offer for Shire to 47 pounds a share on Friday after its three previous bids - the last at 46.50 pounds - were rejected by the rare disease drugs specialist.

Takeda weighs raising Shire bid to more than 47 stg/share: sources

Japan's Takeda Pharmaceutical Co Ltd is considering raising its cash-and-stock bid for London-listed drug maker Shire Plc to approximately 47 pounds ($66) per share or more, people familiar with the matter said on Friday.

Takeda weighs raising Shire bid to more than 47 stg/share-sources

April 20 Japan's Takeda Pharmaceutical Co Ltd is considering raising its cash-and-stock bid for London-listed drug maker Shire Plc to approximately 47 pounds ($66) per share or more, people familiar with the matter said on Friday.

FTSE 100 set for fourth straight week of gains while Reckitt, Shire tumble

LONDON, April 20 Weaker sterling helped Britain's FTSE 100 outperform European markets on Friday, while consumer giant Reckitt Benckiser tumbled after disappointing results and Shire declined as Allergan pulled out of the running to acquire the company.

BRIEF-Allergan confirms does not intend to make Shire

* ALLERGAN NOW CONFIRMS THAT IT DOES NOT INTEND TO MAKE AN OFFER FOR SHIRE Source text for Eikon: Further company coverage: (Reporting by Maiya Keidan)

Select another date: